Islay Capital Management’s CVS Health CVS Stock Holding History

Islay Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,133	Closed	-$170K	–	202
2024 Q1	$170K	Hold	2,133	–	–	0.13%	90
2023 Q4	$168K	Hold	2,133	–	–	0.13%	97
2023 Q3	$149K	Sell	2,133 -414	-16%	-$29.3K	0.12%	98
2023 Q2	$176K	Hold	2,547	–	–	0.16%	93
2023 Q1	$189K	Hold	2,547	–	–	0.18%	93
2022 Q4	$237K	Hold	2,547	–	–	0.27%	85
2022 Q3	$243K	Sell	2,547 -149	-6%	-$14.7K	0.29%	88
2022 Q2	$250K	Sell	2,696 -34	-1%	-$3.32K	0.26%	60
2022 Q1	$276K	Hold	2,730	–	–	0.23%	66
2021 Q4	$282K	Hold	2,730	–	–	0.21%	68
2021 Q3	$232K	Sell	2,730 -95	-3%	-$7.96K	0.18%	71
2021 Q2	$236K	Sell	2,825 -646	-19%	-$52.9K	0.19%	69
2021 Q1	$261K	Sell	3,471 -1,211	-26%	-$88.2K	0.22%	67
2020 Q4	$320K	Hold	4,682	–	–	0.29%	53
2020 Q3	$273K	Buy	4,682 +1,625	+53%	+$101K	0.28%	54
2020 Q2	$199K	Buy	3,057 +2,832	+1,259%	+$178K	0.23%	63
2020 Q1	$13K	Sell	225 -394	-64%	-$26.3K	0.02%	204
2019 Q4	$46K	Buy	+619	New	+$43.5K	0.04%	168

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Islay Capital Management's CVS Position: Q2 2024 in Review

Islay Capital Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,133 shares — an estimated $170K sold.

Islay Capital Management first reported a position in CVS in Q4 2019 and held it in 18 quarters. The position peaked at $320K in Q4 2020. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Islay Capital Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Islay Capital Management sold 2,133 CVS Health shares in Q2 2024, an estimated $170K.
Islay Capital Management first reported a position in CVS Health in Q4 2019 and held it in 18 quarters.
Islay Capital Management's CVS Health position peaked at $320K in Q4 2020.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Islay Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.